Loren J. Schleiden
University of Pittsburgh
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Loren J. Schleiden.
American Journal of Preventive Medicine | 2015
Joshua M. Thorpe; Carolyn T. Thorpe; Richard M. Schulz; Courtney Harold Van Houtven; Loren J. Schleiden
INTRODUCTION Many informal caregivers of dependent midlife and older adults suffer from their own functional limitations. The impact of caregiver functional limitations on care recipient receipt of preventive services is unknown. The purpose of this study is to examine the association between caregiver functional limitations and decreased access to recommended preventive services in dependent care recipients. METHODS Dependent adults (those receiving assistance with activities of daily living or instrumental activities of daily living) and their primary informal caregiver were identified from pooled alternate years (2000-2008) of the nationally representative Medical Expenditure Panel Survey (data analyzed February-October 2014). The impact of caregiver limitations (cognitive, mobility, sensory, emotional health) on care recipients receipt of up to seven different preventive services was assessed via survey-weighted linear and logistic regression. RESULTS Of the 5-year weighted estimate of 14.2 million caregiver-care recipient dyads, 38.0% of caregivers reported at least one functional limitation. The percentage of recommended preventive services received by care recipients was significantly lower if the caregiver had cognitive, mobility, or emotional health limitations. Each type of caregiver functional limitation was negatively associated with at least four different preventive services. CONCLUSIONS Informal caregivers burdened by their own functional impairments may face challenges in facilitating access to preventive care in dependent midlife and older adults. Policies and interventions designed to prevent or mitigate the impact of caregiver functional impairments are critical to the success of community-based models of care for dependent adults.
Journal of the American Geriatrics Society | 2016
Carolyn T. Thorpe; Nicole R. Fowler; Katherine Harrigan; Xinhua Zhao; Yihuang Kang; Joseph T. Hanlon; Loren J. Schleiden; Joshua M. Thorpe
To examine racial and ethnic differences in initiation and time to discontinuation of antidementia medication in Medicare beneficiaries.
International Journal of Pharmacy Practice | 2017
Olufunmilola Abraham; Loren J. Schleiden; Steven M. Albert
To examine older adults’ perspectives regarding managing sleep problems through selection and use of non‐prescription sleep aids, and the role of pharmacists.
Seminars in Arthritis and Rheumatism | 2018
Carolyn T. Thorpe; Joshua M. Thorpe; Tao Jiang; Dylan Atkinson; Yihuang Kang; Loren J. Schleiden; Delesha M. Carpenter; Julie Anne G. McGregor; Susan L. Hogan
OBJECTIVE The Medicare federal insurance program is the most common United States insurer of patients with systemic vasculitis (SV). We compared healthcare utilization and expenditures for Medicare beneficiaries with versus without SV. METHODS This national, retrospective study used 2010 claims and enrollment data for a 100% cohort of Medicare Part A and B beneficiaries with ≥1 claim including a diagnosis for a form of SV (n = 176,498), and a randomly selected group of non-SV beneficiaries (n = 46,561). Outcomes included annual counts of events in 16 categories of medical services (e.g., inpatient stays, physician visits, tests, and imaging events), and total annual Medicare and patient medical expenditures. We used linear regression with bootstrapped standard errors to compare utilization and expenditures by SV status, before and after matching on age and sex. Prescription drug fills and expenditures for SV (n = 95,157) and non-SV (n = 24,992) beneficiaries with Part D drug benefits were also compared. RESULTS After matching, Medicare spent
Research in Social & Administrative Pharmacy | 2018
Loren J. Schleiden; Carolyn T. Thorpe; John P. Cashy; Chester B. Good; Joseph T. Hanlon; Maria K. Mor; Joshua D. Niznik; John R. Pleis; Courtney Harold Van Houtven; Joshua M. Thorpe
11,004 more per patient in 2010 for medical services, and
Journal of the American Geriatrics Society | 2018
Joshua D. Niznik; Song Zhang; Maria K. Mor; Xinhua Zhao; Mary Ersek; Sherrie L. Aspinall; Joshua M. Thorpe; Joseph T. Hanlon; Loren J. Schleiden; Sydney Springer; Carolyn T. Thorpe
773 more on prescription drugs, for SV versus non-SV beneficiaries. SV beneficiaries spent
Archive | 2016
Olufunmilola Abraham; Loren J. Schleiden; Michelle A. Chui
1547 more for medical services and
American Journal of Health-system Pharmacy | 2015
Heather Sakely; Jason Corbo; Kim C. Coley; Melissa Somma McGivney; Carolyn T. Thorpe; Patricia M. Klatt; Loren J. Schleiden; John Zaharoff; Lora Cox-Vance; Vincent Balestrino
211 more for prescription drugs. Except for hospice, SV beneficiaries had greater utilization of all services, including two-to-three times more dialysis events, hospital readmissions, inpatient stays, skilled nursing facility stays, and medical tests. CONCLUSIONS The average Medicare beneficiary with SV incurs about double the annual healthcare expenditures compared to their non-SV counterparts, attributable to increased utilization of almost all categories of care.
Annals of Internal Medicine | 2017
Joshua M. Thorpe; Carolyn T. Thorpe; Chester B. Good; Joseph T. Hanlon; Maria K. Mor; John R. Pleis; Loren J. Schleiden; Courtney Harold Van Houtven
BACKGROUND Obtaining prescription medications from multiple health systems may complicate coordination of care. Older Veterans who obtain medications concurrently through Veterans Affairs (VA) benefits and Medicare Part D benefits (dual users) are at higher risk of unintended negative outcomes. OBJECTIVE To explore characteristics predicting dual drug benefit use from both VA and Medicare Part D in a national sample of older Veterans with dementia. METHODS Administrative data were obtained from the VA and Medicare for a national sample of 110,828 Veterans with dementia ages 68 and older in 2010. Veterans were classified into three drug benefit user groups based on the source of all prescription medications they obtained in 2010: VA-only, Part D-only, and Dual Use. Multinomial logistic regression was used to examine predictors of drug benefit user group. The source of prescriptions was described for each of the ten most frequently used drug classes and opioids. RESULTS Fifty-six percent of Veterans received all of their prescription medications from VA-only, 28% from Part D-only, and 16% from both VA and Part D. Veterans who were eligible for Medicaid or who had a priority group score conferring less generous drug benefits within the VA were more likely to be Part D-only or dual users. Nearly one fourth of Veterans taking opioids concurrently received opioid prescriptions from dual sources (24.7%). CONCLUSIONS Medicaid eligibility and Veteran priority group status, which largely decrease copayments for drugs obtained outside versus within the VA, respectively, were the main factors predicting drug user benefit group. Policies to encourage single-system prescribing and enhance communication across health systems are crucial to preventing negative health outcomes related to care fragmentation.
Sleep Health | 2017
Olufunmilola Abraham; Jia Pu; Loren J. Schleiden; Steven M. Albert
To evaluate the predictive validity of an adapted version of the Minimum Data Set (MDS) Mortality Risk Index—Revised (MMRI‐R) based on MDS version 3.0 assessment items (MMRI‐v3) and to compare the predictive validity of the MMRI‐v3 with that of a single MDS item indicating limited life expectancy (LLE).